Hashtag
Men's Weekly

How NDIS participants on the Gold Coast can get the most out of trusted plan management

Having a trustworthy partner by your side can make all the difference when it comes to managing your National Disability Insuran...

Why Real Estate Rubbish Removal is Essential for Property Success

When it comes to buying, selling, or renting out a property, presentation matters more than most people realise. A property migh...

Common Fire Safety Compliance Mistakes and How to Avoid Them

Image by freepik In Australia, fire safety compliance isn’t just a legal requirement—it’s a critical safeguard for protecting liv...

Why Melbourne Homes Can’t Afford to Ignore Duct Cleaning This Winter

Melbourne winters are long, cold, and unpredictable. When the temperature drops, most households rely heavily on ducted heating ...

How to Choose the Right Size Concrete Mixer for Your Construction Needs

(Source) No matter what type of construction you are undertaking, whether it's a garden patio, driveway repair, or a full-scale...

Unlocking the Power of Hard Chrome: A Comprehensive Guide

Image by freepik Hard chrome has long been celebrated for its remarkable ability to extend the lifespan and performance of metal...


SINGAPORE - Media OutReach - 31 May 2023 - According to a recent study sponsored by Merck, a leading science and technology company, mRNA technology is a "game-changer" for Asia-Pacific (APAC) vaccine manufacturers. Nearly 40 manufacturers participated in the survey.

Filling of Merck
Filling of Merck's synthetic cholesterol, a key component of mRNA-based vaccines and therapeutics, at the company's Darmstadt facility

"Vaccine manufacturers in APAC are looking to build capacity for mRNA technology over the next two to three years, while continuing to produce both traditional and modern cell-based vaccines," said Josephine Cheng, Senior Consultant, Process Solutions APAC at the Life Science business sector of Merck. "Across APAC, governments are investing and supportive of driving therapeutic discovery and manufacturing. With the range of tools we offer, we can better equip vaccine manufacturers to treat the regional and global population."

The study interviewed vaccine manufacturers across APAC, including research institutes, pharmaceutical and biotech companies. Eighty-seven percent deemed mRNA a promising technology, expecting it to be a key modality in the future. This is based on the perception that the mRNA platform benefits from shorter development time and templated manufacturing processes, proven efficacy, lower biohazard risk for operators, and flexibility in covering different types of diseases and variants.

Japan, South Korea, Australia, Indonesia, Singapore, China and India are among the markets actively exploring to develop mRNA technology. Over sixty percent of the vaccine makers prefer to revamp or establish new facilities especially for mRNA with expansion planned over the next two to three years.

To effectively move mRNA forward, respondents highlighted the need for skilled personnel trained in these new technologies, tech-transfer expertise, a reliable supply chain, and mRNA-specific regulatory guidelines.

Merck’s contribution to future vaccine manufacturing
Merck's Life Science business supports mRNA manufacturers helping accelerate speed to market, ensuring safety and efficacy, to reducing complexity across the entire mRNA process to help accelerate delivery of mRNA vaccines to patients worldwide. More information is available on sigmaaldrich.com/vaccines
Hashtag: #Merck

The issuer is solely responsible for the content of this announcement.

Merck

Merck, a leading science and technology company, operates across life science, healthcare and electronics. More than 64,000 employees work to make a positive difference to millions of people's lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2022, Merck generated sales of € 22.2 billion in 66 countries.

Scientific exploration and responsible entrepreneurship have been key to Merck's technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as MilliporeSigma in life science, EMD Serono in healthcare, and EMD Electronics in electronics.

All Merck news releases are distributed by email at the same time they become available on the Merck website. Please go to to register online, change your selection or discontinue this service.

IN THE NEWS

Styling Your Little Princess: Dressing Tips for Your Newborn Girl

Introducing your newborn to the world of style can be an exciting journey for both parent and baby alik.

The best CFD broker 2025': Octa receives yet another award

KUALA LUMPUR, MALAYSIA - Media OutReach Newswire - 27 June 2025 - Octa, a globally regulated and trusted.

Generali Hong Kong Garnered Two Awards at the Insurance Asia Awards 2024

HONG KONG SAR - Media OutReach Newswire - 10 July 2024 - Generali Hong Kong has achieved significant rec.

Arlo Announces New Audio AI Smart Home Security Feature In Upgrade To Secure Plus Service Plan

Newly Added Arlo Intelligence-Powered Feature Empowers Arlo Secure Subscribers to Make Better Informed De.

Qianjiangyuan: "China’s Amazon Rainforest" Nurtures Innovative Examples of Ecological Prot…

QUZHOU, CHINA - Media OutReach Newswire - 14 August 2024 - Aug. 15 of this year marks China's second Nat.

Hong Kong Wraps Up Valuable Participation at WEF Annual Meeting

HONG KONG SAR - Media OutReach Newswire - 24 January 2025 - Financial Secretary of the Hong Kong Special.

Health & Wellness

Telehealth Could be the Catalyst for Better Heart Health in Australia

Hashtag.net.au - avatar Hashtag.net.au

Image by stockking on Freepik Heart disease is one of the leading causes of death in Australia despite decades of advancements in medicine and health education campaigns. More than 400 Australians ...

Disability Care in Melbourne: What Families Need to Know in 2025

Hashtag.net.au - avatar Hashtag.net.au

If you’re supporting a loved one with a disability in Melbourne, you’ll know how important it is to find the right care—and how overwhelming it can be to navigate the system. With the National Disab...

Online Medical Certificate Services: Essential Features to Look Out For

Hashtag.net.au - avatar Hashtag.net.au

"Discover top online medical certificate services! Essential features to look for to get trusted and efficient results." Choosing high-quality services is essential for ensuring reliable, efficient, ...